Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Federal Trade Commission
US Army
Mallinckrodt
QuintilesIMS
Chinese Patent Office
Fish and Richardson
Accenture
Boehringer Ingelheim

Generated: April 26, 2018

DrugPatentWatch Database Preview

Watson Labs Inc Company Profile

« Back to Dashboard

What is the competitive landscape for WATSON LABS INC, and what generic and branded alternatives to WATSON LABS INC drugs are available?

WATSON LABS INC has seventy-nine approved drugs.

There are thirteen tentative approvals on WATSON LABS INC drugs.

Summary for Watson Labs Inc
US Patents:0
Tradenames:62
Ingredients:60
NDAs:79

Drugs and US Patents for Watson Labs Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Inc HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 040008-001 Oct 10, 1995 DISCN No No ➤ Sign Up ➤ Sign Up
Watson Labs Inc AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 062816-004 Oct 24, 1988 DISCN No No ➤ Sign Up ➤ Sign Up
Watson Labs Inc CEFACLOR cefaclor FOR SUSPENSION;ORAL 064204-001 Feb 18, 1998 DISCN No No ➤ Sign Up ➤ Sign Up
Watson Labs Inc BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 077285-002 Aug 15, 2008 AB3 RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
Fish and Richardson
US Department of Justice
Fuji
Chinese Patent Office
Julphar
Moodys
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.